OBI Pharma Inc (台灣浩鼎) chairman Michael Chang (張念慈) was yesterday morning released after posting NT$1 million (US$30,914) bail, as prosecutors listed him as a defendant on insider trading charges.
Chang and four other OBI Pharma executives were summoned for questioning at the Shilin District Prosecutors’ Office in Taipei on Friday, after judicial investigators searched the company headquarters and its laboratories to gather evidence earlier that day.
Prosecutors said they had made breakthroughs in the investigation and therefore questioned the other four company executives, including OBI Pharma general manager Huang Hsiu-mei (黃秀美), head of research and development Yu Cheng-te (游丞德), administration division manager Liao Tsung-chih (廖宗智) and finance division manager Chang Sui-fen (張穗芬), to gather information related to the case.
Photo: Wang Yi-sung, Taipei Times
Prosecutors said there is sufficient evidence of their involvement in insider trading to list them as defendants in the case, but they were released without bail yesterday.
OBI Pharma yesterday issued a statement, saying the company did not engage in any illegal activities, and asked the justice agencies to conduct a fair and unbiased investigation to clear the company of the charges.
The statement criticized the search process, with judicial investigators confiscating private documents and material containing proprietary business information, some of which relates to the company’s core technology development, including results of more than 10 years of research, which it said would adversely affect the rights of company shareholders if leaked and deal a severe blow to the nation’s pharmaceutical, healthcare and bioscience industries.
Academia Sinica President Wong Chi-huey (翁啟惠), a prominent Taiwanese-American biochemist and research scientist, has also been embroiled in the affair.
He returned to Taiwan from the US on Friday and met with President Ma Ying-jeou (馬英九) to discuss the case; he again apologized to the public for the controversy, saying he was not involved in insider trading and had no intention of manipulating OBI Pharma shares, some of which were held in his daughter’s name.
While he was in the US, Wong tendered his resignation on March 31, but Ma rejected it.
In related news, Academia Sinica yesterday settled on three candidates for its next president, with the list to be forwarded to the Presidential Office for selection, Academia Sinica Vice President Wang Fan-sen (王汎森) said.
Additional reporting by Wu Po-wei
‘NO SECURITY RISK’: The Railway Bureau reassured the public that the technicians’ activities were limited to technical guidance and did not involve sensitive systems The Railway Bureau yesterday said it had invited eight Chinese technicians to assist with an airport MRT construction project. The bureau issued the confirmation after an Internet user said Chinese nationals had entered the construction zone of Taiwan Taoyuan International Airport’s Terminal 3 project. They asked why “individuals from an enemy state” were allowed access to such a major national infrastructure project, which raised serious concerns over Taiwan’s industrial safety, sensitive systems and information security. The bureau’s Northern Region Engineering Branch Office said subcontractor Taiwan Handle Industrial Co (台灣手把工業) of the Taoyuan airport MRT’s “Contract No. CU05 Project A14 Station Civil, MEP &
A US uncrewed surface vessel (USV) encountered multiple Chinese warships during an autonomous transit of the Taiwan Strait, US defense company Seasats said in a statement on Wednesday. Seasats announced that a Lightfish USV had completed the first autonomous transit of the Taiwan Strait. Over five days, the USV traversed the entire length of the Strait while constantly monitoring surface vessel traffic, the company said. The Lightfish encountered multiple Chinese warships, one of which was a Chinese People’s Liberation Army Navy (PLAN) Type 056 corvette, it said. The Chinese vessels were operating “well within Taiwan’s exclusive economic zone without transmitting their identity via the
‘BOOMING’: ’ The number of partners we have here is incredible. You can see from their stock prices. They’re doing so well, they’re so happy,’ Jensen Huang said Nvidia Corp’s spending in Taiwan has ballooned to about US$150 billion a year, 10 times the US$10 billion to US$15 billion the company spent five years ago, Nvidia chief executive officer Jensen Huang (黃仁勳) said yesterday, suggesting Taiwan’s strategic importance in the global artificial intelligence (AI) supply chain. “Taiwan is the epicenter of the AI revolution. This is where the chips come, packaging comes. This is where the systems are made. This is where AI supercomputers were created,” Huang said at a meeting for the company’s employees in Beitou-Shilin Technology Park (北投士林科技園區) in Taipei, the planned site of Nvidia’s Taipei headquarters. “Taiwan
GREATER REACH? Auto parts and wood products would face tariffs of up to 15%, matching those targeting the EU, Japan and South Korea, Vice Premier said The US has announced that preferential tariff treatment for Taiwan’s non-semiconductor Section 232 goods would take effect retroactively from May 1, the Executive Yuan said yesterday. The US government yesterday posted a notice on the Federal Register’s public inspection Web site previewing tariff concessions for Taiwan under a memorandum of understanding (MOU) on Taiwan-US investment after two months of negotiations. The MOU signed on Jan. 15 stipulated three major preferential tariff arrangements: a 15 percent “reciprocal” tariff rate for Taiwan without stacking most-favored nation (MFN) rates; preferential Section 232 treatment for semiconductors and related products; and preferential Section 232 treatment for non-semiconductor
RSS